Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs

Journal:

Nature Communications

Published:

2025-05-13

DOI:

10.1038/s41467-025-59796-x

Affiliations:

36

Authors:

56

Go to article

Institutions	Authors	Share
University of New South Wales (UNSW Sydney), Australia	24.500000 24.500000 24.500000	0.44
Westmead Hospital (WSLHD), Australia	2.666667	0.05
Prince of Wales Hospital, Australia	2.333333	0.04
Australian National University (ANU), Australia	2.000000	0.04
Monash University, Australia	2.000000	0.04
The University of Auckland, New Zealand	2.000000	0.04
King's College London (KCL), United Kingdom (UK)	2.000000	0.04
Royal North Shore Hospital (RNSH), Australia	2.000000	0.04
Nepean Hospital, USYD, Australia	2.000000	0.04
Royal Prince Alfred Hospital (RPAH), USYD, Australia	1.500000	0.03
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia	1.000000	0.02
Austin Health, Australia	1.000000	0.02
Cabrini Hospital, Australia	1.000000	0.02
Royal Adelaide Hospital (RAH), Australia	1.000000	0.02
Blacktown and Mount Druitt Hospital (BMDH), Australia	1.000000	0.02
Wollongong Hospital, Australia	1.000000	0.02
Liverpool Hospital, Australia	1.000000	0.02
Gosford Hospital, Australia	1.000000	0.02
St George Hospital (SGH), SESLHD, Australia	1.000000	0.02
Otway Pharmaceutical Development & Consulting (OPDC), Australia	1.000000	0.02
The University of Hong Kong (HKU), China	1.000000	0.02
The Heart Research Institute (HRI), Australia	0.500000	0.01
Ingham Institute, Australia	0.500000	0.01
Calvary Mater Newcastle, Australia	0.333333	0.01
The University of Newcastle (UON), Australia	0.333333	0.01
Hunter Cancer Research Alliance (HCRA), Australia	0.333333	0.01

Interested in Oncology and Carcinogenesis?